# US 2016/0256383 A1 · Compositions and methods for combination ingredient delivery

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0256383 A1
- Document ID: US20160256383A1
- Status: Published application
- Kind: A1
- Application number: 15/159,433
- Filed: 2016-05-19
- Published: 2016-09-08
- Earliest claimed: 2015-02-11
- Assignees: The Fix, LLC
- Applicants: The FIX, LLC
- Inventors: Michael K. Allio; Stephen Lane; Marco Wo
- Web page: https://patentgrep.com/patent/US20160256383A1

## CPC

- A61K 9/0056: {Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals}
- A23G 3/563: {products with an inedible support, e.g. a stick}
- A23L 2/52: Adding ingredients (adding preservatives A23B70/10)
- A61K 9/0095: {Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches (A61K9/0007 takes precedence; eatable gels or foams A61K9/0056; oral mucosa adhesive forms A61K9/006)}
- A61K 31/045: Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K 31/047: having two or more hydroxy groups, e.g. sorbitol
- A61K 31/05: Phenols {(cannabinoids A61K31/658)}
- A61K 31/09: having two or more such linkages
- A61K 31/135: having aromatic rings {, e.g. ketamine, nortriptyline (methadone A61K31/137)}
- A61K 31/137: Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine {or methadone}
- A61K 31/167: having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A61K 31/19: Carboxylic acids, e.g. valproic acid (salicylic acid A61K31/60)
- A61K 31/192: having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid {(cannabinoids A61K31/658)}
- A61K 31/194: having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
- A61K 31/245: Amino benzoic acid types, e.g. procaine, novocaine (salicylic acid esters A61K31/60)
- A61K 31/29: Antimony or bismuth compounds
- A61K 31/4402: only substituted in position 2, e.g. pheniramine, bisacodyl
- A61K 31/4453: only substituted in position 1, e.g. propipocaine, diperodon
- A61K 31/485: Morphinan derivatives, e.g. morphine, codeine
- A61K 31/522: having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
- A61K 31/616: by carboxylic acids, e.g. acetylsalicylic acid
- A61K 31/695: Silicon compounds
- A61K 31/7004: Monosaccharides having only carbon, hydrogen and oxygen atoms
- A61K 31/7028: Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K 31/80: Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
- A61K 33/10: Carbonates; Bicarbonates
- A61K 35/644: Beeswax; Propolis; Royal jelly; Honey
- A61K 36/185: Magnoliopsida (dicotyledons)
- A61K 36/28: Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K 36/53: Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K 36/577: {Malvaceae (Mallow family)}
- A61K 36/59: Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
- A61K 36/73: Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K 36/752: Citrus, e.g. lime, orange or lemon
- A61K 36/899: Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K 36/9066: Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
- A61K 36/9068: Zingiber, e.g. garden ginger
- A61K 47/46: Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23G: COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION

## Abstract

Described herein are compositions, methods, and devices for relief of a cough, cold, sore throat, or allergy, or a related symptom. Also described herein are compositions, methods, and devices for the prevention, treatment and/or amelioration of a digestive illness or digestive discomfort, or a related symptom of either.

## Claims

### Claim at position 1

1-47. (canceled)

### Claim 48

A composition comprising:
a plurality of active pharmaceutical ingredients, wherein the plurality of active pharmaceutical ingredients comprises an analgesic, antihistamine, antitussive, expectorant, nasal decongestant, or demulcent, wherein the plurality of active pharmaceutical ingredients provide relief for a cold, cough, or sore throat, or a related symptom, and wherein the plurality of active pharmaceutical ingredients comprises:
a. aspirin or acetaminophen present in an amount of about 325 to 650 mg;
b. menthol present in an amount of about 5 to 10 mg; and
c. benzocaine present in an amount about 2 to 15 mg; and
a plurality of botanical ingredients, wherein the plurality of botanical ingredients comprises:
a. cooked isomalt present in an amount of about 18000 to 21000 mg;
b. elderberry tincture present in an amount of about 1000 to 1200 mg;
c. honey present in an amount of about 400 to 600 mg;
d. tartaric acid present in an amount of about 30 to 60 mg;
e. marshmallow powder present in an amount of about 30 to 60 mg;
f. lemon oil present in an amount of about 10 to 30 mg;
g. Echinacea extract present in an amount of about 8 to 16 mg;
h. tinofend present in an amount of about 5 to 15 mg;
i. Stevia, 40% present in an amount of about 5 to 15 mg; and
j. Thyme oil present in an amount of about 1 to 10 mg.

### Claim 49

A composition comprising:
a plurality of active pharmaceutical ingredients, wherein the plurality of active pharmaceutical ingredients comprises an analgesic, antihistamine, antitussive, expectorant, nasal decongestant, or demulcent, wherein the plurality of active pharmaceutical ingredients provide relief for a cold, cough, or sore throat, or a related symptom, and wherein the plurality of active pharmaceutical ingredients comprises:
a. aspirin present in an amount of about 70 to 90 mg;
b. menthol present in an amount of about 0.5 to 3 mg; and
c. benzocaine present in an amount about 0.5 to 3 mg; and
a plurality of botanical ingredients, wherein the plurality of botanical ingredients comprises:
a. cooked isomalt present in an amount of about 4000 to 6000 mg;
b. elderberry tincture present in an amount of about 200 to 400 mg;
c. honey present in an amount of about 50 to 300 mg;
d. tartaric acid present in an amount of about 5 to 20 mg;
e. marshmallow powder present in an amount of about 5 to 20 mg;
f. lemon oil present in an amount of about 1 to 10 mg;
g. Echinacea extract present in an amount of about 1 to 10 mg;
h. tinofend present in an amount of about 0.5 to 5 mg;
i. Stevia, 40% present in an amount of about 0.5 to 5 mg; and
j. Thyme oil present in an amount of about 0.5 to 5 mg.

### Claim 50

(canceled)

### Claim 51

A composition for cold, cough, or sore throat relief,
wherein the composition is in the form of a lollipop and comprises:
a. aspirin present in an amount of about 325 to 650 mg;
b. menthol present in an amount of about 5 to 10 mg;
c. benzocaine present in an amount about 2 to 15 mg;
d. cooked isomalt present in an amount of about 19974 mg;
e. elderberry tincture present in an amount of about 1100 mg;
f. honey present in an amount of about 440 mg;
g. tartaric acid present in an amount of about 55 mg;
h. marshmallow powder present in an amount of about 40 mg;
i. lemon oil present in an amount of about 20 mg;
j. Echinacea extract present in an amount of about 12 mg;
k. tinofend present in an amount of about 10 mg;
l. Stevia, 40% present in an amount of about 9 mg; and
m. Thyme oil present in an amount of about 4 mg.

### Claim 52

A composition for cold, cough, or sore throat relief,
wherein the composition is in the form of a lozenge and comprises:
a. aspirin present in an amount of about 81.25 mg;
b. menthol present in an amount of about 1.5 mg;
c. benzocaine present in an amount about 1.25 mg;
d. cooked isomalt present in an amount of about 4993.5 mg;
e. elderberry tincture present in an amount of about 275 mg;
f. honey present in an amount of about 110 mg;
g. tartaric acid present in an amount of about 13.75 mg;
h. marshmallow powder present in an amount of about 10 mg;
i. lemon oil present in an amount of about 5 mg;
j. Echinacea extract present in an amount of about 3 mg;
k. tinofend present in an amount of about 2.5 mg;
l. Stevia, 40% present in an amount of about 2.25 mg; and
m. Thyme oil present in an amount of about 1 mg.

### Claim 53

A composition for sore throat relief, comprising:
a plurality of active pharmaceutical ingredients, wherein the plurality of active pharmaceutical ingredients comprises an analgesic, antihistamine, antitussive, expectorant, nasal decongestant, or demulcent; and
a plurality of botanical ingredients, wherein the plurality of botanical ingredients comprises cooked isomalt, elderberry tincture, honey, tartaric acid, marshmallow powder, lemon oil, Echinacea extract, tinofend, stevia, and thyme oil, wherein the plurality of active pharmaceutical ingredients and the plurality of botanical ingredients are present in a ratio by weight of about 1:32 to 1:65.

### Claim 54

(canceled)

### Claim 55 (depends on 53)

The composition claim 53, wherein the plurality of active pharmaceutical ingredients and the plurality of botanical ingredients are present in a ratio by weight of 1:64.

### Claim 56 (depends on 53)

The composition of claim 53, wherein the composition comprises multiple layers.

### Claim 57 (depends on 56)

The composition of claim 56, wherein the multiple layers comprise:
a. an inner layer; wherein the inner layer is solid, semi-solid, gelatinous, or liquid; and
b. an outer layer, wherein the outer layer is solid, semi-solid or gelatinous.

### Claim 58 (depends on 57)

The composition of claim 57, wherein the outer layer is a shape and size such that it has a form that complements the interior of a mouth.

### Claim 59 (depends on 57)

The composition of claim 57, wherein the inner layer comprises the plurality of botanical ingredients and the outer layer comprises the plurality of pharmaceutical ingredients.

### Claim 60 (depends on 57)

The composition of claim 57, wherein the outer layer comprises the plurality of botanical ingredients and the inner layer comprises the plurality of pharmaceutical ingredients.

### Claim 61 (depends on 57)

The composition of claim 57, wherein the inner layer and the outer layer are separated in a patterned form.

### Claim 62 (depends on 53)

The composition of claim 53, wherein the composition comprises multiple matrices, wherein each matrix comprises a different group of ingredients.

### Claim at position 17

63-126. (canceled)

### Claim 127

A composition comprising:
a plurality of active pharmaceutical ingredients, wherein the plurality of active pharmaceutical ingredient provides for prevention, amelioration or treatment of a disease state associated with a digestive illness, and wherein the plurality of active pharmaceutical ingredients comprises:
a. calcium carbonate present in an amount of about 1000 to 2000 mg; and
b. simethicone present in an amount of about 50 to 200 mg; and
a plurality of botanical ingredients, and wherein the plurality of botanical ingredients is present comprises:
a. honey present in an amount about 5000 to 6000 mg;
b. oats present in an amount about 4000 to 5000 mg;
c. catnip glycerine present in an amount of about 500 to 1000 mg;
d. chamomile flower present in an amount of about 300 to 600 mg;
e. marshmallow powder present in an amount of about 200 to 500 mg;
f. meadowsweet present in an amount of about 200 to 500 mg;
g. ginger powder present in an amount of about 100 to 300 mg; and
h. turmeric present in an amount of about 50 to 150 mg.

### Claim 128 (depends on 127)

The composition of claim 127, wherein the composition is in the form of a slurry.

### Claim 129

A composition comprising:
a plurality of active pharmaceutical ingredients, wherein the plurality of active pharmaceutical ingredient provides for prevention, amelioration or treatment of a disease state associated with a digestive illness, and wherein the plurality of active pharmaceutical ingredients comprises:
a. calcium carbonate present in an amount of about 1000 to 2000 mg; and
b. simethicone present in an amount of about 50 to 200 mg; and
a plurality of botanical ingredients, and wherein the plurality of botanical ingredients is present comprises:
a. honey present in an amount about 4000 to 5000 mg;
b. meadowsweet present in an amount of about 2500 to 3500 mg;
c. chamomile present in an amount of about 1500 to 2000 mg;
d. lemon balm present in an amount of about 2000 to 3500 mg; and
f. turmeric present in an amount of about 400 to 600 mg.

### Claim 130 (depends on 129)

The composition of claim 129, wherein the composition is in a carbonated or creamy form.

### Claim 131

A composition for digestive relief, comprising:
a plurality of active pharmaceutical ingredients, wherein the plurality of active pharmaceutical ingredients comprises an antacid, antidiarrheal, antiemetic, antiflatulent, stomach acidifier, or overindulgence reliever; and
a plurality of botanical ingredients, wherein the plurality of botanical ingredients comprises cooked isomalt, elderberry tincture, honey, tartaric acid, marshmallow powder, lemon oil, Echinacea extract, tinofend, stevia, and thyme oil, and wherein the plurality of active pharmaceutical ingredients and the plurality of botanical ingredients are present in a ratio by weight of about 1:5 to 1:11.

### Claim 132

(canceled)

### Claim 133 (depends on 131)

The composition of claim 131, wherein the plurality of active pharmaceutical ingredients and the plurality of botanical ingredients are present in a ratio by weight of 1:7.5.

### Claim at position 25

134-137. (canceled)

### Claim 138 (depends on 48)

The composition claim 48, wherein the composition is in the form of a lollipop, lozenge, powder, or liquid.

### Claim 139 (depends on 49)

The composition claim 49, wherein the composition is in the form of a lollipop, lozenge, powder, or liquid.

### Claim 140 (depends on 53)

The composition claim 53, wherein:
the expectorant is guaifenesin;
the decongestant is phenylephrine or pseudoephedrine;
the demulcent is glycerin;
the antitussive is menthol;
the analgesic acetaminophen, ibuprofin, aspirin or naproxen;
the anesthetic is benzocaine, lidocaine, dyclonine, or hexyrescorcinol; or
the antihistamine is brompheniramine, chlorpheniramine, diphenhydramine, or dimenhydrinate.

### Claim 141 (depends on 140)

The composition of claim 140, wherein the plurality of botanical ingredients enhances the activity of at least one of the active pharmaceutical ingredients to provide relief for coughing, pain, chest congestion, nasal congestion, fever, runny nose, muscle ache, fatigue, loss of appetite, or headache.

### Claim 142 (depends on 127)

The composition of claim 127, further comprising a microstructure which comprises the plurality of active pharmaceutical ingredients or the plurality of botanical ingredients.

### Claim 143 (depends on 129)

The composition of claim 129, further comprising a microstructure which comprises the plurality of active pharmaceutical ingredients or the plurality of botanical ingredients.

### Claim 144 (depends on 131)

The composition of claim 131, further comprising a microstructure which comprises the plurality of active pharmaceutical ingredients or the plurality of botanical ingredients.

### Claim 145 (depends on 131)

The composition of claim 131, wherein the composition is in a carbonated or creamy form.

### Claim 146 (depends on 131)

The composition of claim 131, wherein:
the antacid is calcium carbonate or bismuth subsalicylate;
the antidiarrheal is alumina powder, bismuth subsalicylate, calcium gluconate, calcium polycarbophil, carboxymethylcellulose sodium, charcoal, glycine, homatrophine methylbromide, hyocyamine sulfate, kaolin, lactobacillus acidophilus, lactobacillus bulgaricus, loperamine HCl, opium powder, opium tincture, paregoric, pectin, phenyl salicylate, psyllium husk, polycarbophil, potassium carbonate, scopolamine hydrobromide, sodium carboxymethylcellulose, or zinc phenlsulfonate;
the antiemetic is dimenhydrinate or meclizine hydrochloride;
the antiflatulent is simethicone;
the stomach acidifier is glutamic acid hydrochloride; or
the overindulgence reliever is acetaminophen, aluminum hydroxide, aluminum hydroxide gel, aspirin, bismuth subsalicylate, caffeine, fructose, magnesium carbonate, magnesium trisilicate, sodium citrate in solution, or sodium acetylsalicylate.

### Claim 147 (depends on 146)

The composition of claim 146, wherein the plurality of botanical ingredients enhances the activity of at least one of the active pharmaceutical ingredients to provide relief for a digestive illness associated with a food allergy, food sensitivity, celiac disease, irritable bowel syndrome (IBS), overindulgence in food or alcohol, gastroesophageal reflux disease (GERD), ulcerative colitis, Crohn's disease, bacterial infection, parasitic infection, or viral infection.
